Non-invasive liver fibrosis assessment and HCV treatment initiation within a systematic screening program in HIV/HCV coinfected patients

BACKGROUND AND AIM: Hepatitis C virus (HCV) therapy should be considered without delay in all patients with significant (SIGFIB) or advanced liver fibrosis (ADVFIB). We aimed to investigate the rates of treatment initiation with interferon-free regimens within a screening program for SIGFIB/ADVFIB i...

Descripción completa

Detalles Bibliográficos
Autores principales: Chromy, David, Schwabl, Philipp, Bucsics, Theresa, Scheiner, Bernhard, Strassl, Robert, Mayer, Florian, Aichelburg, Maximilian C., Grabmeier-Pfistershammer, Katharina, Trauner, Michael, Peck-Radosavljevic, Markus, Reiberger, Thomas, Mandorfer, Mattias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816107/
https://www.ncbi.nlm.nih.gov/pubmed/28744597
http://dx.doi.org/10.1007/s00508-017-1231-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816107/
https://www.ncbi.nlm.nih.gov/pubmed/28744597
http://dx.doi.org/10.1007/s00508-017-1231-x

Ejemplares similares